Neal Sharpe

Statistics

Publications

Citations

255

H-Index

Active since

2017

Affiliations

Eloxx Pharmaceuticals (United States)(Current)

Neal Sharpe is an author at Eloxx Pharmaceuticals (United States) specializing in clinical pharmacology, pharmacology, and process-related impurity identification.

Publications per year

2017–2020

Publications

Impurities in Oligonucleotide Drug Substances and Drug Products

Daniel C. Capaldi, Andy Teasdale, Scott P. Henry et al. · Nucleic Acid Therapeutics · 2017 · 130 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +15

Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX‐02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers

Andi Leubitz, Anat Frydman‐Marom, Neal Sharpe et al. · Clinical Pharmacology in Drug Development · 2019 · 71 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins

Daniel K. Crawford, Iris Alroy, Neal Sharpe et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 54 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

1–3 of 3